Financial statements Genesis Pharm Spółka Z Ograniczoną Odpowiedzialnością
Balance sheet data of GENESIS PHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 7 752 752,22 | 7 114 446,36 | 9 426 445,22 | 10 092 189,10 |
| A. Fixed assets | 230 077,46 | 360 706,83 | 278 475,66 | 206 119,06 |
| B. Current assets | 7 522 674,76 | 6 753 739,53 | 9 147 969,56 | 9 886 070,04 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 7 752 752,22 | 7 114 446,36 | 9 426 445,22 | 10 092 189,10 |
| A. Equity | 4 248 530,56 | 3 508 900,09 | 3 974 651,01 | 4 347 356,59 |
| B. Liabilities and provisions for liabilities | 3 504 221,66 | 3 605 546,27 | 5 451 794,21 | 5 744 832,51 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 3 504 221,66 | 3 605 546,27 | 5 451 794,21 | 5 744 832,51 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.